Pulse Biosciences Aktie
WKN DE: A2AMY9 / ISIN: US74587B1017
04.02.2025 14:56:11
|
Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market
(RTTNews) - Pulse Biosciences, Inc. (PLSE), a novel bioelectric medicine company, Tuesday announced the appointment of Jon Skinner as Chief Financial Officer, with effect from February 3.
Shares of Pulse Biosciences are increasing by 6% in the pre-market trading.
Skinner most recently served as Vice President, FP&A and Investor Relations at Copeland
In the pre-market trading, Pulse Biosciences is 5.20% higher at $21.45 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pulse Biosciences Incmehr Nachrichten
11.08.25 |
Ausblick: Pulse Biosciences veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) |
Analysen zu Pulse Biosciences Incmehr Analysen
Aktien in diesem Artikel
Pulse Biosciences Inc | 14,30 | -2,72% |
|